HomePTPI • NASDAQ
add
Petros Pharmaceuticals Inc
Previous close
$0.36
Day range
$0.35 - $0.38
Year range
$0.22 - $2.27
Market cap
3.77M USD
Avg Volume
3.81M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.58M | -5.87% |
Operating expense | 3.63M | 12.78% |
Net income | -2.22M | 51.19% |
Net profit margin | -140.87 | 48.15% |
Earnings per share | -0.53 | — |
EBITDA | -1.60M | -42.27% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.89M | -78.33% |
Total assets | 20.69M | -46.82% |
Total liabilities | 17.58M | -44.83% |
Total equity | 3.12M | — |
Shares outstanding | 10.01M | — |
Price to book | 1.17 | — |
Return on assets | -25.51% | — |
Return on capital | -42.72% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.22M | 51.19% |
Cash from operations | -771.25K | 80.94% |
Cash from investing | -19.14K | — |
Cash from financing | -2.77M | -118.97% |
Net change in cash | -3.57M | -133.68% |
Free cash flow | 1.07M | 206.93% |
About
Founded
2020
Website
Employees
21
